Clinical Trials Directory

Trials / Completed

CompletedNCT01306864

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Clinical Evaluation of Hemospray: Hemostasis of Active GI Luminal Tract Bleeding

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Cook Group Incorporated · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.

Conditions

Interventions

TypeNameDescription
DEVICEHemospray KitHemostasis of Arterial GI Bleeding

Timeline

Start date
2011-12-01
Primary completion
2017-04-30
Completion
2017-05-29
First posted
2011-03-02
Last updated
2018-02-05

Locations

12 sites across 4 countries: Canada, Hong Kong, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT01306864. Inclusion in this directory is not an endorsement.

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding (NCT01306864) · Clinical Trials Directory